Phase II trial of abraxane [Paclitaxel] and capecitabine in metastatic colon cancer (COL 01)
Phase of Trial: Phase II
Latest Information Update: 23 Sep 2009
At a glance
- Drugs Capecitabine; Paclitaxel
- Indications Colorectal cancer
- Focus Therapeutic Use
- 23 Sep 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 23 Sep 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 19 Mar 2008 New trial record.